Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Pre-Treatment Serum Albumin Level as a Means of Improving Prognostic Models in Peripheral T-Cell Lymphomas: A Study From the Latin American Group of Lymphomas (Gell)

Hematological Oncology

English

Inhibition of Bromodomain and Extra-Terminal Proteins (BET) as a Potential Therapeutic Approach in Haematological Malignancies: Emerging Preclinical and Clinical Evidence

Therapeutic Advances in Hematology

Hematology

2015

English

Safety of Lisocabtagene Maraleucel Given With Durvalumab in Patients With Relapsed/Refractory Aggressive B-Cell Non Hodgkin Lymphoma: First Results From the Platform Study

Hematological Oncology

English

Off-Label Use in Lymphoma Patients in Switzerland

Hematological Oncology

English

Double Hit Lymphoma in the Northern Region of England-A Retrospective Analysis of Patient and Disease Characteristics, Treatment Delivered and Survival

Hematological Oncology

English

Effects on the Human Immune System After Obinutuzumab Monotherapy Treatment

Hematological Oncology

English

Clinical Outcomes in Patients With Epstein-Barr Virus (Ebv)-Positive Non-B Cell Lymphoma at the Ohio State University James Comprehensive Cancer Center (Osu James Ccc)

Hematological Oncology

English

Combination of Nivolumab and Bendamustine in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Hematological Oncology

English

Case Series of Nivolumab Treatment in Patients With Relapsed/Refractory Hiv-Related Lymphomas

Hematological Oncology

English

Decitabine Plus R-Chop in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma: Interim Results of a Phase I/Ii Study

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Pre-Treatment Serum Albumin Level as a Means of Improving Prognostic Models in Peripheral T-Cell Lymphomas: A Study From the Latin American Group of Lymphomas (Gell)

Inhibition of Bromodomain and Extra-Terminal Proteins (BET) as a Potential Therapeutic Approach in Haematological Malignancies: Emerging Preclinical and Clinical Evidence

Safety of Lisocabtagene Maraleucel Given With Durvalumab in Patients With Relapsed/Refractory Aggressive B-Cell Non Hodgkin Lymphoma: First Results From the Platform Study

Off-Label Use in Lymphoma Patients in Switzerland

Double Hit Lymphoma in the Northern Region of England-A Retrospective Analysis of Patient and Disease Characteristics, Treatment Delivered and Survival

Effects on the Human Immune System After Obinutuzumab Monotherapy Treatment

Clinical Outcomes in Patients With Epstein-Barr Virus (Ebv)-Positive Non-B Cell Lymphoma at the Ohio State University James Comprehensive Cancer Center (Osu James Ccc)

Combination of Nivolumab and Bendamustine in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Case Series of Nivolumab Treatment in Patients With Relapsed/Refractory Hiv-Related Lymphomas

Decitabine Plus R-Chop in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma: Interim Results of a Phase I/Ii Study